Immunocore Holdings plc (IMCR)

NASDAQ: IMCR · USD

$32.7

+0.75 (+2.4%)· Recorded snapshot

Market cap	1.7B
Revenue (ttm)	430.8M
Net income (ttm)	-18.1M
EPS (ttm)	-$0.36
Shares out	51.5M
Volume	173,302
Beta	0.82

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 430.8M
Net income (ttm): -18.1M
EPS (ttm): -$0.36
Market cap: 1.7B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Trzymaj

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 13.4P50 20.2P75 35.7

Trailing P/En/a

P25 15.4P50 25.8P75 43.5

ROE-4.5

P25 -113.8P50 -46.5P75 -0.9

ROIC-0.2

P25 -68.5P50 -27.1P75 1.8

Benchmarks · 1M

All IMCR indicators

Market & fundamental data

Available fields

211

Groups with data

Currency

USD

Showing 211 of 211 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001671927
Company name	Immunocore Holdings plc
Country	United Kingdom
Country code	US
CUSIP number	45258D105
Earnings date	2026-11-09
Earnings time	bmo
Employees	524
Employees change	31
Employees growth	6.29%
Enterprise value	$1.2B
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2008
Industry	Biotechnology
IPO date	2021-02-05
Is primary listing	Yes
Is SPAC	No
ISIN number	US45258D1054
Last 10-K release date	2026-02-25
Last earnings date	2026-08-06
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$1.7B
Market cap category	Small-Cap
Next earnings date	2026-11-09
Options	Yes
Price	$32.72
Price currency	USD
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-28
Symbol	IMCR
Website	https://www.immunocore.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-1.09%
EV/EBITDA	1,594.28x
EV/Sales	2.8x
FCF / EV yield	-3.41%
FCF yield	-2.49%
Forward EV/Sales	2.51x
Forward P/S	3.44x
P/B ratio	3.92x
P/S ratio	3.83x
Price / tangible book value	3.93x
Price/EBITDA ratio	2,183.24x
Sector forward P/E	23.56x
Sector P/E	50.13x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-0.66%
EBITDA margin	0.18%
Gross margin	32.87%
Operating margin	-0.66%
Pretax margin	-0.63%
Profit margin	-4.2%
Profit per employee	$-34,492
Revenue per employee	$822,090
ROA	-0.16%
ROA (5Y)	-10.32%
ROCE	-0.32%
ROE	-4.47%
ROE (5Y)	-34.96%
ROIC	-0.21%
SBC / revenue	7.87%
Tax / revenue	3.56%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	2
EPS growth years	4
FCF growth (Q)	-40.74%
Gross profit growth	23.76%
Gross profit growth (Q)	46.49%
Gross profit growth 3Y	15.95%
Net income growth quarters	2
Net income growth years	2
OCF growth (Q)	-38.65%
Revenue growth	20.96%
Revenue growth (Q)	18.34%
Revenue growth (QoQ)	8.67%
Revenue growth 3Y	25.19%
Revenue growth 5Y	61.86%
Revenue growth quarters	19
Revenue growth years	4

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-6.2M
Depreciation and amortization	$3.6M
EBIT	$-2.9M
EBITDA	$756,000
EPS	$-0.36
FCF per share	$-0.80
Financing cash flow	$23.3M
Free cash flow	$-41.2M
Free cash flow minus SBC	$-75M
Gross profit	$141.6M
Income taxes	$15.3M
Investing cash flow	$7.8M
Net cash flow	$-3M
Net income	$-18.1M
Operating cash flow minus SBC	$-68.8M
Operating income	$-2.9M
Revenue	$430.8M
Stock-based compensation	$33.9M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	1.65
Book value per share	$8.15
Debt / EBITDA	575.34
Debt / equity	1.04
Interest coverage	-0.23
Long-term assets	$68.4M
Long-term liabilities	$464.4M
Net cash (debt)	$445.3M
Net cash / market cap	26.98%
Net cash growth	-0.25%
Net debt / EBITDA	-588.96
Net debt / equity	-1.06
Piotroski F-Score	2
Property, plant and equipment	$49.9M
Shareholders' equity	$419.8M
Tangible book value	$419.8M
Tangible book value per share	$8.15
Total assets	$1.1B
Total cash	$880.2M
Total debt	$435M
Total liabilities	$699.6M
WACC	7.38%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.39
Current assets	$1.1B
Current liabilities	$235.2M
Current ratio	4.47
Inventory turnover	43.66
Net working capital	$-62.5M
Quick ratio	4.15
Working capital	$815.8M
Working capital turnover	0.52

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-1.14%
Dividend yield	0%
Shareholder yield	-1.14%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$31.56
1D price change	2.36%
1M price change	4.93%
1M total return	4.93%
1W price change	-1.12%
1W total return	-1.12%
1Y price change	-3.66%
1Y return CAGR	-3.66%
1Y total return	-3.66%
20-day SMA	$30.22
200-day SMA	$31.78
3M price change	-4.55%
3M total return	-4.55%
3Y price change	-24.77%
3Y return CAGR	-9.05%
3Y total return	-24.77%
50-day SMA	$32.59
50-day SMA vs 200-day SMA	50over200
52-week high	$40.72
52-week high date	2025-12-05
52-week low	$27.50
52-week low date	2026-10-14
5Y price change	-15.01%
5Y return CAGR	-3.2%
5Y total return	-15.01%
6M price change	12.87%
6M total return	12.87%
All-time high	$76.98
All-time high date	2024-02-01
All-time low	$18.43
All-time low date	2022-01-21
Average true range (ATR)	$1.34
Average volume	500.6K
Beta (1Y)	0.01
Beta (2Y)	0.58
Beta (5Y)	0.82
Change from 52-week high	-19.65%
Change from 52-week low	18.96%
Change from all-time high	-58.13%
Change from all-time low	74.91%
Change from open	2.49%
Day's gap	-0.13%
Dollar volume	$5.7M
High price	$32.72
Low price	$31.92
Monthly RSI	46.67
Open price	$31.92
Position in 52-week range	99.38%
Previous close	$31.96
Price vs 150-day SMA	2.14%
Price vs 20-day SMA	6.66%
Price vs 200-day SMA	1.43%
Price vs 50-day SMA	-1.08%
Relative volume	0.35
Return from IPO open	-21.83%
Return from IPO price	23.27%
RSI	57.25
Sharpe ratio	-0.03
Sharpe ratio (3Y)	-0.18
Sharpe ratio (5Y)	0.08
Sortino ratio	0.12
Sortino ratio (3Y)	-0.12
Sortino ratio (5Y)	0.23
Volume	173.3K
Weekly RSI	50.77
YTD price change	-7.13%
YTD total return	-7.13%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	45.8M
Float percentage	89%
Shares change (QoQ)	-3.7%
Shares change (YoY)	1.14%
Shares held by insiders	0.1%
Shares held by institutions	87.02%
Shares outstanding	51.5M
Short % of shares	17.05%
Short ratio	20.7 days

Deeper analysis on IMCR

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this IMCR report

Is a complete IMCR research report available?

No complete published report is available for Immunocore Holdings plc (IMCR) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Immunocore Holdings plc (IMCR)

Price

Financial snapshot

Fair-value bridge

Latest news · IMCR

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All IMCR indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on IMCR

Frequently asked questions